Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Brain Dev ; 46(1): 49-56, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37657962

RESUMO

OBJECTIVE: Transcutaneous auricular vagus nerve stimulation (taVNS) was performed in two patients suffering structural focal epilepsy with preserved intellectual ability to show the feasibility of taVNS for specific patient groups. CASE PRESENTATIONS: Patient 1 was a 24-year-old woman with frontal lobe epilepsy who had weekly hyperkinetic seizures despite multiple anti-seizure medications. Patient 2 was a 27-year-old woman with parietal lobe epilepsy and focal cortical dysplasia in the vicinity of the lipoma in the corpus callosum. She experienced weekly focal-impaired awareness seizures even with anti-seizure medication. taVNS was applied to the left earlobe of both patients at 1.5 mA, 25 Hz, 250 µs pulse width, and 30 s stimulation with 30 s rest for 4 h per day. Over an 8-week baseline and 20 weeks of stimulation, the rate of reduction in seizure frequency was evaluated, along with quality-of-life using the Short-Form 36-Item Health survey. RESULTS: At baseline, we measured up to 11 and 12 focal seizures per week in Patient 1 and 2, respectively, with both patients achieving seizure freedom after 4 and 20 weeks taVNS, respectively. Patient 1 and 2 were observed for 18 and 14 months, respectively, including the clinical trial and follow-up observation period. Quality-of-life ratings increased in both patients, and no significant adverse events occurred during the study period. During the maintenance period after 20 weeks, seizures remained absent in Patient 1, and seizures remained reduced in Patient 2. CONCLUSION: Our results demonstrate that taVNS may be a promising tool for structural focal epilepsy with preserved cognitive function. A multicenter double-blind clinical trial is needed to confirm the role of taVNS as an anti-seizure tool.


Assuntos
Epilepsia do Lobo Frontal , Estimulação Elétrica Nervosa Transcutânea , Estimulação do Nervo Vago , Adulto , Feminino , Humanos , Adulto Jovem , Convulsões/terapia , Convulsões/etiologia , Estimulação Elétrica Nervosa Transcutânea/métodos , Nervo Vago/fisiologia , Estimulação do Nervo Vago/métodos
2.
Cytogenet Genome Res ; 163(3-4): 103-109, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37285811

RESUMO

Radiation-related normal tissue injury sustained during cancer radiotherapy or in a radiological or mass casualty nuclear incident is a major health concern. Reducing the risk and mitigating consequences of radiation injury could have a broad impact on cancer patients and citizens. Efforts to discover biomarkers that can determine radiation dose, predict tissue damage, and aid medical triage are underway. Exposure to ionizing radiation causes changes in gene, protein, and metabolite expression that needs to be understood to provide a holistic picture for treating acute and chronic radiation-induced toxicities. We present evidence that both RNA (mRNA, microRNA, long noncoding RNA) and metabolomic assays may provide useful biomarkers of radiation injury. RNA markers may provide information on early pathway alterations after radiation injury that can predict damage and implicate downstream targets for mitigation. In contrast, metabolomics is impacted by changes in epigenetics, genetics, and proteomics and can be considered a downstream marker that incorporates all these changes to provide an assessment of what is currently happening within an organ. We highlight research from the past 10 years to understand how biomarkers may be used to improve personalized medicine in cancer therapy and medical decision-making in mass casualty scenarios.


Assuntos
MicroRNAs , Neoplasias , Lesões por Radiação , Humanos , Lesões por Radiação/etiologia , Lesões por Radiação/genética , MicroRNAs/genética , Biomarcadores , Epigênese Genética , Neoplasias/genética , Neoplasias/radioterapia , Radiometria
3.
J Phys Chem B ; 125(7): 1755-1759, 2021 02 25.
Artigo em Inglês | MEDLINE | ID: mdl-33565877

RESUMO

Metal nanoparticles (NPs) may serve as biomarkers, as the surfaces can be chemically modified to enable an analysis of several biosystems, including plant pathogenesis. We supplied metal oxide NPs including those of ZnO, TiO2, Y2O3, and Y2O3 doped with europium to plants of eight species of the Poaceae and Cucurbitaceae families. The plants were grown using hydroponics, where NPs were incorporated into the cultivation media. Energy-dispersive X-ray spectroscopy was used to detect the uptake of NPs by the plant in regions of the root, stem, and leaf. Results show that ZnO NPs were taken up more readily by the plants compared to other NPs. Unmodified NPs were only delivered up till the stems and not the leaves; however, when the surfaces were modified using photoinduced hydrophilization supplemented with poly(ethylene glycol), NPs were delivered to the leaves of plants. It is suggested that plants readily take up metals such as zinc that function as nutrients. Additionally, hydrophilization of NP surfaces using UV irradiation enhances uptake, where modified ZnO and TiO2 NPs may be delivered to the leaves. These findings may be used to design biomarker systems for detecting tissue damage and infections in various crops.


Assuntos
Cucurbitaceae , Nanopartículas Metálicas , Nanopartículas , Óxido de Zinco , Humanos , Óxidos , Poaceae , Titânio , Zinco
4.
Intern Med ; 59(11): 1401-1405, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32475907

RESUMO

A 69-year-old man was referred to our department with acute hepatitis. He had been newly treated with benidipine hydrochloride for two months. His blood test results were as follows: aspartate aminotransferase, 1,614 IU/L; alanine aminotransferase, 1,091 IU/L and anti-smooth muscle antibody, ×80. Needle liver biopsy specimen showed interface hepatitis with mainly lymphocytic infiltration and bridging fibrosis in the periportal area. Immunohistochemistry revealed lymphocytic infiltration positive for IgG4. We diagnosed him with IgG4-related AIH with an etiology that was suspected of being drug-induced. Oral prednisolone was started and then tapered after achieving biochemical remission. Hepatitis recurred after the cessation of steroids; however, remission was achieved with ursodeoxycholic acid.


Assuntos
Hepatite Autoimune/tratamento farmacológico , Hepatite Autoimune/etiologia , Hepatite Crônica/tratamento farmacológico , Imunoglobulina G/sangue , Nifedipino/efeitos adversos , Nifedipino/uso terapêutico , Prednisolona/uso terapêutico , Idoso , Anti-Inflamatórios/uso terapêutico , Colagogos e Coleréticos/uso terapêutico , Hepatite Autoimune/diagnóstico , Humanos , Japão , Masculino , Nifedipino/análogos & derivados , Resultado do Tratamento , Ácido Ursodesoxicólico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA